Wegovy News

Two studies indicate that increasing the dosage of weight loss drugs like Mounjaro and Wegovy does not lead to significantly greater weight loss, potentially sa

GLP-1 weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are effective even at low starter doses. These drugs are initially prescribed at a low dose

After years of rising obesity rates in the US, there are now indications of a potential turning point, possibly influenced by the rapid increase in the use of w

The article details the severe side effects experienced by patients taking the weight-loss drug Wegovy, including constant nausea, fatigue, and depression, with

GLP-1 drugs like Ozempic and Wegovy are revolutionizing obesity treatment by shifting focus to proactive management, but their high cost and unequal insurance c

A pharmacist has issued a new warning for individuals taking Mounjaro or Wegovy, advising them to watch out for a specific list of symptoms as new alerts come i

Despite Wegovy making Novo Nordisk Europe's most valuable company, the Danish drugmaker faces challenges in finding its next blockbuster drug, with a recent pha

A nationwide trial is set to investigate the effectiveness of specialist community-based NHS support hubs in helping individuals maintain weight loss achieved w

A new trial suggests that the drug used in Ozempic and Wegovy pills may also be effective in treating alcohol use disorder, a condition for which no new medicat

A doctor has claimed that women increase their risk of a 'life-changing' side effect by taking weight loss injections like Mounjaro and Wegovy.

The popularity of weight-loss drugs like Wegovy and Mounjaro has led to numerous reports of side effects, including 'Ozempic face' and hair loss. While digestiv

A new study indicates that weight loss and diabetes medications such as Mounjaro, Ozempic, and Wegovy are associated with an increased risk of hair loss.

A warning has been issued to users of Mounjaro, Wegovy, and Ozempic as these drugs have been linked to hair loss, prompting a major study and review following h

New research indicates that popular weight loss medications such as Mounjaro, Ozempic, and Wegovy are associated with an increased risk of hair loss.

A major study by Danish researchers suggests that women using hormonal birth control may be more prone to weight gain, finding they are up to 63 percent more li

Two weight-loss drugmakers, Novo Nordisk and Eli Lilly, are engaged in a legal battle over the effectiveness of their respective medications.

A study of 41,000 users suggests that alcoholics taking weight loss drugs like Wegovy and Mounjaro experience fewer hospitalizations. Researchers propose explor

A new study indicates that GLP-1 weight-loss drugs, such as Ozempic and Wegovy, are linked to a 17% reduction in worker sick leave. This suggests a potential fo

Novo Nordisk has sued rival Eli Lilly in a U.S. federal court, alleging false advertising regarding the efficacy of Lilly's weight-loss medicines compared to No

Novo Nordisk has filed a lawsuit against Eli Lilly, alleging that its rival used outdated data in advertisements to falsely claim its weight-loss products were

Wegovy has been approved by the drug regulator as the first GLP-1 medication for adults suffering from fatty liver disease.

India's drug regulator has approved Novo Nordisk's obesity drug Wegovy for the treatment of MASH, a severe form of fatty liver disease, following a committee re

Lucy Cavendish, one of the first women in Britain to try the new Wegovy weight-loss pill, shares her initial experiences, noting it feels very different from pr

Dr. Reddy's गुणवत्ता संबंधी समस्या के कारण सेमाग्लूटाइड की आपूर्ति में देरी करेगा, जिससे उसके शेयर प्रभावित हुए हैं; सेमाग्लूटाइड नोवो नॉर्डिस्क की वेगोवी और ओज